Corticosteroids but not Infliximab Increase Short-term Postoperative Infectious Complications in Patients with Ulcerative Colitis

被引:195
作者
Ferrante, M. [1 ]
D'Hoore, A.
Vermeire, S.
Declerck, S.
Noman, M.
Van Assche, G.
Hoffman, I.
Rutgeerts, P.
Penninckx, F.
机构
[1] Univ Hosp Leuven, Dept Gastroenterol, B-300 Louvain, Belgium
关键词
corticosteroids; ulcerative colitis; postoperative infectious complications; infliximab; IPAA; pouch; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; NECROSIS-FACTOR; RESTORATIVE PROCTOCOLECTOMY; RHEUMATOID-ARTHRITIS; INCREASED RISK; THERAPY; SURGERY; POUCH; MORTALITY;
D O I
10.1002/ibd.20863
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background: Recent reports suggest that the preoperative use Of infliximab (IFX) increases postoperative infectious complications in patients with ulcerative colitis (UC). Therefore, we determined the impact of IFX oil postoperative infectious complications. Methods: A consecutive group of 141 UC patients (41% female. median age 39.8 years) undergoing (procto)colectomy was studied. Postoperative infectious complications were compared between 22 patients who received IFX within 12 weeks prior to (procto)colectomy (IFX group) and 119 patients who (lid not (control group). Short-term infectious complications. consisting of anastomotic leaks. pelvic abscesses, Wound infections, and nonsurgical site infections, were recorded within 30 days after primary Surgery. Results: At primary surgery there was no significant difference ender. disease extent, smoking behavior, body mass index, and concomitant medication (including corticosteroids) between the groups. Patients in the IFX group less offer) underwent restorative proctocolectomy without defunctioning ileostomy (9% versus 34%. P = 0,022), had a significantly shorter median (interquartile range. IQR) disease duration (2.7 [1.2-8.6] versus 5.9 [2.6-13.0] years, P < 0.036) and a significantly higher C-reactive protein level at primary surgery (51.7 [9.9-103.6] versus 19.1 [7.5-42.6] mg/L, P = 0.023). There was no short-term mortality. A moderate-to-high close of corticosteroids (>= 20 mg methylprednisolone for >= 2 months, odds ratio 5.19 [95% confidence interval [CI]: 1.72-15.66] P = 0.003) and a restorative proctocolectomy without defunctioning ileostomy (odds ratio 6.45 [95% Cl: 2.12-19.64]. P = 0.001) were independent predictors of short-term postoperative infectious complications. Conclusion: Corticosteroids and a restorative proctocolectomy without defunctioning ileostomy, but not IFX, are associated with an increased risk of short-term postoperative infectious complications in UC.
引用
收藏
页码:1062 / 1070
页数:9
相关论文
共 25 条
[1]
Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients [J].
Appau, Kweku A. ;
Fazio, Victor W. ;
Shen, Bo ;
Church, James M. ;
Lashner, Bret ;
Remzi, Feza ;
Brzezinski, Aaron ;
Strong, Scott A. ;
Hammel, Jeffrey ;
Kiran, Ravi P. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (10) :1738-1744
[2]
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[3]
Brzezinski A, 2002, GASTROENTEROLOGY, V122, pA617
[4]
Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy [J].
Colombel, JF ;
Loftus, EV ;
Tremaine, WJ ;
Pemberton, JH ;
Wolff, BG ;
Young-Fadok, T ;
Harmsen, WS ;
Schleck, CD ;
Sandborn, WJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (05) :878-883
[5]
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease [J].
Cornillie, F ;
Shealy, D ;
D'Haens, G ;
Geboes, K ;
Van Assche, G ;
Ceuppens, J ;
Wagner, C ;
Schaible, T ;
Plevy, SE ;
Targan, SR ;
Rutgeerts, P .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (04) :463-473
[6]
D'Haens G, 2008, GASTROENTEROLOGY, V134, pA140
[7]
den Broeder AA, 2007, J RHEUMATOL, V34, P689
[8]
ILEAL POUCH-ANAL ANASTOMOSES COMPLICATIONS AND FUNCTION IN 1005 PATIENTS [J].
FAZIO, VW ;
ZIV, Y ;
CHURCH, JM ;
OAKLEY, JR ;
LAVERY, IC ;
MILSOM, JW ;
SCHROEDER, TK .
ANNALS OF SURGERY, 1995, 222 (02) :120-127
[9]
Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis [J].
Giles, JT ;
Bartlett, SJ ;
Gelber, AC ;
Nanda, S ;
Fontaine, K ;
Ruffing, V ;
Bathon, JM .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (02) :333-337
[10]
RESTORATIVE PROCTOCOLECTOMY IN ELECTIVE AND EMERGENCY CASES OF ULCERATIVE-COLITIS [J].
HEYVAERT, G ;
PENNINCKX, F ;
FILEZ, L ;
AERTS, R ;
KERREMANS, R ;
RUTGEERTS, P .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1994, 9 (02) :73-76